Asset Management One Co.
Ltd. reduced its position in Medical Properties Trust, Inc. (NYSE: MPW) by 4.3% during the third quarter, as stated in the company’s most recent filing with the Securities and Exchange Commission (SEC). The company ended the period with 1,135,671 shares of equity in the real estate investment trust, following the sale of 51,251 shares earlier.
Asset Management One Co.
Ltd. was the owner of Medical Properties Trust at the end of the most recent reporting period.
At that time, the value of the Medical Properties Trust was $13,469,000, representing approximately 0.19% of the total.
Over the last few months, several other institutional investors and hedge funds have purchased and sold the company’s stock.
Lincoln National Corporation increased its Medical Properties Trust holdings by 9.5% over the third quarter.
Lincoln National Corp. now has a total of 27,017 shares of the real estate investment trust following the purchase of an additional 2,347 shares over time. The shares have a combined value of $320,000 thanks to Lincoln National Corp.
During the third quarter of the fiscal year, Andesa Financial Management Inc.
Invested in Medical Properties Trust in the amount of $129,000. First Republic Investment Management Inc.
Increased the percentage of Medical Properties Trust shares that it held by 16.1 percent during the third quarter. First Republic Investment Management Inc. now has a total of 85,783 shares of the real estate investment trust following purchasing 11,927 shares during the period in question. These shares have a combined market value of $1,017,000.
During the third quarter, Sheaff Brock Investment Advisors LLC increased the percentage of Medical Properties Trust in which it is invested by 6.3%. Sheaff Brock Investment Advisors LLC is now the owner of 20,213 real estate investment trust shares.
At the current market price, these shares are worth $240,000. The company increased its shareholding by 1,203 over the year by purchasing additional stock.
And finally, during the third quarter of this year, Duality Advisers LP placed an investment in Medical Properties Trust that was worth $715,000 in total. Currently, 80.31% of the company’s shares are owned by various institutional investors, including hedge funds.
Several analysts recently had reports on the stock they had written and published. The “overweight” rating that KeyCorp had previously assigned to Medical Properties Trust was changed to a “neutral” rating in a research note published on January 19.
In addition, the company lowered its price objective, going from $18.00 to $16.00.
Barclays decreased its target price for Medical Properties Trust shares from $23.00 to $19.00 in a research report made public by the brokerage firm on Friday, October 21. The report was made available to the public. Once more, the brokerage firm gave the stock an “overweight” recommendation, which indicates that they believe it will go up in price.
Mizuho lowered their target price on Medical Properties Trust from $20.00 to $18.00 in a report made public on Friday, December 2.
Bank of America raised their price objective on Medical Properties Trust from $13.00 to $16.00 and upgraded the stock from a “neutral” rating to a “buy” rating in a research report published on Monday, November 14. The report was available on the company’s website. They explained their choice by stating that it was derived from their situation evaluation. The target price that the Royal Bank of Canada has set for the shares of Medical Properties Trust has been reduced from $20.00 to $18.00, as stated in a report that was made public on Tuesday, October 4. The final and most significant adjustment was made here. There are a total of six research analysts who advise investors to maintain their current holdings of the stock. Four analysts have a buy rating for the stock, while the remaining analyst has a strong buy rating. The current consensus rating for Medical Properties Trust is “Moderate Buy,” and the company’s average price objective is $16.73, according to information that Bloomberg provided.
When trading started on Thursday, the price of a share of MPW was $12.39 per share. Over the previous twelve months, the share price of Medical Properties Trust, Inc. has ranged from a low of $9.90 to a high of $23.18. The debt-to-equity ratio, the current ratio, and the quick ratio are all equal to 1.07. The current ratio is 1.98, and the current and quick ratios are also 1.98. The company’s market capitalization of $7.41 billion can be attributed to several factors, including its price-to-earnings ratio of 5.96, its price-to-earnings-to-growth ratio of 0.75, and its beta value of 0.87. For the past fifty and two hundred days, the price of a share of the company’s stock has been moving back and forth between the range of $12.26 and $13.22.
In addition, the business recently announced and paid out a quarterly dividend, which was done on the 12th of this month. The dividend was paid out to shareholders. The $0.29 dividend payment was made to shareholders on December 8, provided that they were recorded holders as of the business day before. The result of this is that there will be a dividend yield of 9.36% and that there will be a dividend payment of $1.16 each year.
As of December 7, it was considered that this dividend had been paid out in its entirety. The payout ratio that Medical Properties Trust currently operates at is 55.77%.
Self-directed real estate investment trust Medical Properties Trust, Inc. has set its sights on investing in, purchasing, and developing net-leased healthcare facilities (REITs).
Its portfolio includes medical office buildings, rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, and medical office buildings for other institutions specializing in a single medical specialty.
Leave a comment